Literature DB >> 70499

Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin.

P C Harpel.   

Abstract

alpha2-Plasmin inhibitor and alpha2-macroglobulin were allowed to compete for the protease plasmin. The binding of the enzyme to these inhibitors was assessed by two different but comparable methods. The interactions were completed in 10 s of incubation, and transfer of plasmin from one inhibitor to the other did not occur. Almost as much plasmin was bound to alpha2-plasmin inhibitor in mixtures containing a large molar excess of alpha2-macroglobulin relative to plasmin or alpha2-plasmin inhibitor, as was bound in mixtures not containing alpha2-macroblobulin. These studies demonstrate directly the effectiveness of alpha2-plasmin inhibitor in binding and inhibiting plasmin in the presence of alpha2-macroglobulin, and suggest that the alpha2-plasmin inhibitor may be the major circulating plasmin inhibitor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70499      PMCID: PMC2180822          DOI: 10.1084/jem.146.4.1033

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

2.  The primary inhibitor of plasmin in human plasma.

Authors:  S Müllertz; I Clemmensen
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Alpha-1-antitrypsin, an inhibitor for thrombin and plasmin.

Authors:  H Gans; B H Tan
Journal:  Clin Chim Acta       Date:  1967-07       Impact factor: 3.786

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Inhibition of plasmin activity by alpha-2-macroglobulin.

Authors:  P O Ganrot
Journal:  Clin Chim Acta       Date:  1967-05       Impact factor: 3.786

7.  Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.

Authors:  P C Harpel; N R Cooper
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

8.  Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.

Authors:  P S NORMAN; B M HILL
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

9.  Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.

Authors:  D Collen
Journal:  Eur J Biochem       Date:  1976-10-01

10.  Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.

Authors:  M Moroi; N Aoki
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

View more
  13 in total

Review 1.  The human plasma fibrinolytic system: regulation and control.

Authors:  K C Robbins
Journal:  Mol Cell Biochem       Date:  1978-08-16       Impact factor: 3.396

2.  Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

3.  Physiological activation of plasminogen in full term newborn infants.

Authors:  M M Hilali; B E Gilliver
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

4.  Detection of an alteration of the alpha 2-macroglobulin gene in a patient with chronic lung disease and serum alpha 2-macroglobulin deficiency.

Authors:  W Poller; J Barth; B Voss
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

5.  Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model.

Authors:  J P de Boer; A A Creasey; A Chang; J J Abbink; D Roem; A J Eerenberg; C E Hack; F B Taylor
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Role of thrombin and plasmin in development of delayed hypersensitivity reaction in guinea pig skin.

Authors:  T Imamura; T Kambara
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

7.  Inhibitory spectrum of alpha 2-plasmin inhibitor.

Authors:  H Saito; G H Goldsmith; M Moroi; N Aoki
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.

Authors:  N Aoki; H Saito; T Kamiya; K Koie; Y Sakata; M Kobakura
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

9.  Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.

Authors:  S L Gonias; M Einarsson; S V Pizzo
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

10.  Functional modifications of alpha 2-macroglobulin by primary amines. Kinetics of inactivation of alpha 2-macroglobulin by methylamine, and formation of anomalous complexes with trypsin.

Authors:  F Van Leuven; J J Cassiman; H Van den Berghe
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.